Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03478371 · ClinicalTrials.gov registry record · NA
In-use Study of Four Different Tampons
A NA study of Menstruation, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 94
- Enrollment target
- 1
- Study location
NCT03478371: Completed NA study of Menstruation, sponsored by Procter and Gamble.
NCT03478371 is a NA study of Menstruation that has completed, run by Procter and Gamble. The registered enrollment target is 94 participants, below the 166,728-participant average among 3 other Menstruation trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03478371, a NA study of Menstruation, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the impact on vaginal health of four different tampons using gynecologic assessment and subjective assessment of comfort during in-use conditions
Primary Outcome
The physician examiner determined tampon tolerance based on the following: 1) Vaginal erythema (0-4 scale), 2) vaginal lacerations (presence or absence), 3) vaginal abrasions (presence or absence), 4) vaginal pH, 5) vaginal discharge
Conditions Studied
Interventions
- DEVICE tampon D
- DEVICE tampon M
- DEVICE tampon T
- DEVICE tampon V
Study Locations (1)
Ohio
- Synexus-US - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2018-01-16 |
| Est. Completion | 2018-07-18 |
| Phase | NA |
What the finished NCT03478371 record still lists
NCT03478371 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 166,728-participant average among 3 other Menstruation trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Menstruation appearing as the primary indexed condition, and to 4 interventions - of which tampon D is the first listed.
NCT03478371 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03478371 about?
NCT03478371 is a clinical study titled "In-use Study of Four Different Tampons". This study will evaluate the impact on vaginal health of four different tampons using gynecologic assessment and subjective assessment of comfort during in-use conditions
What is the current status of trial NCT03478371?
This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2018-01-16. Estimated completion is 2018-07-18.
What conditions does trial NCT03478371 study?
This clinical trial studies the following conditions: Menstruation.
What interventions are being tested in trial NCT03478371?
The interventions under investigation include: tampon D (DEVICE), tampon M (DEVICE), tampon T (DEVICE), tampon V (DEVICE).
Who is sponsoring clinical trial NCT03478371?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03478371 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menstruation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI